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The Use of Pulmonary Artery Catheter in Sepsis Patients: A 
Literature Review
Dimitrios Velissarisa, Vasilios Karamouzosa, Ioanna Kotronib, Charalampos Pierrakosc, 
 Menelaos Karanikolasd, e
Abstract
This article was to review the literature regarding the use of the pul-
monary artery catheter (PAC) in the management of patients with 
sepsis and septic shock. A PubMed search was conducted in order 
to identify publications evaluating the use of PAC as a tool for man-
agement and therapeutic guidance in patients with sepsis. The bibli-
ographies of all identified publications were reviewed for additional 
relevant references. Much information is identified in the literature 
regarding the indications for pulmonary artery catheterization in the 
assessment and treatment of patients with sepsis. Although the PAC 
has been widely used for many years, there is no clear benefit with 
regard to outcome, and there is controversy regarding its use. It is not 
clear that use of the PAC contributes to reduced morbidity and mortal-
ity in patients with sepsis. The role of the PAC is becoming less clear, 
as newer, non-invasive techniques are developed for hemodynamic 
assessment of sepsis patients. Large, well-designed clinical trials are 
needed to better assess the role and potential benefit from use of the 
PAC in sepsis.
Keywords: Sepsis; Monitoring; Pulmonary artery; Catheter; Inten-
sive care; Critical care; Morbidity; Mortality; Circulation 
Introduction
Several studies assessing the adverse effects of sepsis on the 
heart have shown that myocardial dysfunction is a common, 
severe complication of sepsis, and the mechanisms responsi-
ble for development of myocardial dysfunction are complex. 
Hemodynamic monitoring is important in the management of 
critically ill sepsis patients, because it can help assess hemo-
dynamic variables, identify causes of hemodynamic instabil-
ity and monitor response to therapy. However, the benefit of 
hemodynamic monitoring in the management of sepsis and 
septic shock remains unproven. The pulmonary artery cath-
eter (PAC) is an invasive device used largely in the intensive 
care unit (ICU) for monitoring, assessment and management 
of hemodynamic variables in critically ill patients, including 
patients with sepsis. PAC use varies between different ICUs 
and is influenced by several factors, including ICU organiza-
tion, physician preference, patient insurance, race and clinical 
characteristics [1], but overall the use of the PAC in critical 
care is declining. The indication for PAC use is matter of de-
bate because, despite earlier promising results, several well-
designed studies have failed to show a clear benefit with regard 
to mortality or other major outcomes [2, 3]. The aim of this 
review is to summarize the current literature on the use of the 
PAC in critically ill sepsis patients.
Literature Search Methods
We conducted a PubMed search using the combinations of the 
words “Swan-Ganz catheter”, “pulmonary artery catheter” and 
“sepsis”. All identified manuscripts, including reviews and 
case series, were considered for inclusion in this review. We 
also reviewed the bibliographies of all identified manuscripts 
in an attempt to find additional relevant publications. We lim-
ited the scope of our work to studies on humans, published 
in English in the last 20 years, but we also included studies 
published in other languages, if they had a meaningful abstract 
in English. Two authors reviewed all identified manuscripts 
for relevance to this review, and articles deemed relevant were 
included. Any disagreement regarding relevance of specific 
publications was resolved by consensus, after discussion be-
tween the authors. All clinical studies identified and used in 
this review are summarized in Table 1 [4-20].
Literature Search Results
In 2014, a publication by Gopal et al compared cardiac out-
put measurements derived from thermodilution using a PAC 
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vs. non-invasive cardiac output using the Mostcare monitor 
in 22 consecutive sepsis patients, and noted that, compared to 
thermodilution, the non-invasive method had high error rate 
[4]. Similarly, a study by Slagt published in 2013 compared 
cardiac output measurements using thermodilution with PAC 
(COtd) vs. the FloTrac/VigileoTM (COfv) system by uncali-
brated arterial pressure waveform analysis in 19 patients with 
septic shock. This study showed strong correlation between 
COfv and COtd values (r = 0.53, P < 0.001) but also showed 
that COfv underestimates COtd in septic shock with low sys-
temic vascular resistance (SVR) [5].
A publication by Trof in 2012 reported results of a pro-
Table 1.  Clinical Studies Evaluating the Role of the Pulmonary Artery Catheter in Patients With Sepsis or Septic Shock
Author/year Origin/year Study design Findings





study, 22 pts with septic  
shock
Non-invasive cardiac output monitoring had high error rate compared to 
thermodilution using PAC.





study, 19 pts with septic  
shock
Strong correlation between cardiac output measurements using 
thermodilution with PAC (COtd) vs. the FloTrac/VigileoTM (COfv). 
COfv underestimates COtd in septic shock with low SVR.




RCT, 120 pts Important outcomes, including ventilator-free days, LOS, organ failure  





Retrospective study, 140  
sepsis pts
Comparison before vs. after introducing PAC based protocol in sepsis: 
PAC use was associated with higher vasopressor use, higher first day 
but lower overall IV fluid use and reduced ventilator and ICU days.




Prospective cohort study, 
14 pts with septic shock
Excellent correlation between CCO(PAC) vs. pulse-contour analysis 
using PiCCO system (r2 = 0.714, P < 0.0001), but limited precision of  
single CCO(PCCO) measurements vs. CCO(PAC).
Siddiqui, 
2005 [9]
Karachi, Pakistan Retrospective chart review,  
10 pts





Nashville, TN,  
USA
Fluid and Catheter 
Treatment Trial (FACTT)
PAC-guided therapy was associated with higher incidence of  
complications and no improvement in survival.
Conservative fluid management improved lung function and resulted in  
shorter mechanical ventilation and ICU stay.
Shah et al, 
2005 [12]
New York, NY  
USA
Meta-analysis of 13 RCTs 
from 1985 to 2005
PAC use does not seem to increase mortality or LOS. However, because 
clinical trials exclude patients for whom a PAC is required, patients  
excluded from these trials could perhaps benefit from PAC.
Richard et al 
2003 [13]
Paris, France RCT, 36 ICUs, 676 pts PAC use did not affect morbidity or mortality in ARDS, PAC related  
infection observed in 10 patients (2.8%).





prospective cohort, 1,010 
ICU admissions in adults  
with sepsis
Patients with PAC had slightly (but not significantly) lower mortality 
and hospital charges, but significantly higher risk of renal failure within  
28 days.




RCT, 258 pts Risk of catheter colonization and bacteremia not 
significantly different when PAC used for 4 vs. 7 days.
Rhodes, 
2002 [20]
London, UK RCT, 201 ICU pts (including 
101 pts with sepsis)
Patients in the PAC group received significantly more fluids in the first 
24 h, had significantly higher renal failure and thrombocytopenia, but  
there was no difference in mortality.
Sakka et al, 
2000 [16]
Jena, Germany Prospective study, 12 sepsis 
or septic shock ICU pts
PAC use not justified solely for CO measurement, because CO can be  
obtained with similar accuracy from non-invasive methods.
Connors et al, 
1996 [17]
Cleveland, OH,  
USA
Prospective cohort study,  
5,735 ICU pts
PAC use associated with increased resource utilization, higher mortality  
in several subgroups, including patients with sepsis.
Schoenenberger 
et al, 1995 [18]
Basel, 
Switzerland
Prospective study, 47 pts Data obtained after PAC insertion resulted in major change of treatment  
plan in 21% of patients.
Jardin et al, 
1994 [19]
Boulogne, France Prospective study, 32 pts Comparing invasive (using PAC) vs. non-invasive (using 
echocardiography) hemodynamic evaluation in sepsis. PCWP unreliable 
index of preload, possible overestimation of cardiac output using  
thermodilution.
CCO(PAC): continuous cardiac output by PAC; ICU: intensive care unit; LOS: length of stay; PAC: pulmonary artery catheter; pts: patients; RCT: 
randomized controlled trial.
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spective, randomized clinical trial (RCT) assessing the hemo-
dynamic management of critically ill patients with shock using 
transpulmonary thermodilution vs. pulmonary artery occlusion 
pressure. The study included 72 patients with septic shock and 
48 patients with non-septic shock (120 patients in total) and 
showed that important outcomes, including ventilator-free 
days, length of stay, organ failure and mortality were not sig-
nificantly different between the two groups. Patients in non-
septic shock treated with PAC-based algorithm had fewer me-
chanical ventilation days and shorter ICU stay compared to 
the transpulmonary thermodilution algorithm, but there was no 
significant difference in patients with septic shock [6].
A retrospective study from the Netherlands published by 
Bethlehem in 2012 evaluated fluid balance and the need for 
catecholamines before vs. after introduction of a PAC-based 
protocol in patients with severe sepsis or septic shock admitted 
to a 22-bed mixed ICU in a tertiary care hospital. In this study, 
patients treated with a PAC-based protocol received norepi-
neprine more frequently and at significantly higher maximum 
doses (0.12 (0.03 - 0.19) μg/kg/min, n = 59 vs. 0.02 (0 - 0.17) 
μg/kg/min, n = 39, P = 0.000) and had significantly higher 
positive fluid balance (6.1 ± 2.6 vs. 3.8 ± 2.4 L, P < 0.001) on 
the first ICU day, but had significantly lower cumulative fluid 
balance after 7 days (9.4 ± 7.4 vs. 13 ± 7.6 L, P = 0.001) com-
pared with patients in the historical control group. The study 
concluded that introduction of a PAC-based protocol was as-
sociated with greater need for vasopressors, higher early but 
lower overall need for IV fluids and significant reduction in 
ventilator and ICU days [7].
A review paper on myocardial dysfunction in severe sep-
sis published by Jozwiak in 2011 suggested that echocardiog-
raphy is the best method for diagnosis of sepsis-induced myo-
cardial dysfunction, but mentioned invasive methods, such as 
transpulmonary thermodilution monitor and hemodynamic as-
sessment via pulmonary artery catheterization as useful tools 
to alert clinicians about myocardial dysfunction and to monitor 
the response to inotropic therapy [21].
A multicenter longitudinal study from Hamilton, Canada, 
published by Koo et al in 2011 reviewed records of 1,921 pa-
tients who received PAC within the first 2 ICU days, in five 
different ICUs over a 5-year period (2002 - 2006). Multiple 
logistic regression was used to determine variables associated 
with PAC use and whether these variables changed over time. 
This analysis showed that patient factors predicting the use of 
PAC included severity of illness, as measured by the Acute 
Physiology and Chronic Health Evaluation II (APACHE II) 
score (odds ratio (OR): 1.05; confidence interval (CI): 1.04 - 
1.06; P < 0.0001), elective surgery (OR: 2.82; CI: 2.29 - 3.48; 
P < 0.0001), cardiogenic shock (OR: 5.31; CI: 3.35 - 8.42; P < 
0.0001), sepsis (OR: 2.83; CI: 1.94 - 4.13; P < 0.0001), use of 
vasoactive medications (OR: 4.04; CI: 3.47 - 4.71; P < 0.0001), 
mechanical ventilation (OR: 2.21; CI: 1.86 - 2.63; P < 0.0001), 
and abdominal aortic aneurysm repair (OR: 10.91; CI: 8.24 - 
14.45; P < 0.0001). Non-patient factors associated with PAC 
use were ICU preference and the base specialty of the attend-
ing physician (P < 0.001). Overall, PAC use decreased from 
16.4% to 6.5% of patients over this 5-year period [22].
An article published by Frazier in 2008 reviewed the role, 
efficacy and complications of PAC use over a decade, and sug-
gested that published data do not support routine PAC use [23].
A small prospective cohort study published by Spohr et 
al from the University of Heidelberg, in Germany in 2007 
evaluated continuous cardiac output by PAC vs. pulse-contour 
analysis using the PiCCO system in 14 surgical ICU patients 
with septic shock and showed very strong correlation between 
the two measurement methods (r = 0.781, P < 0.0001). How-
ever, the study also assessed the relationships between the 
global end-diastolic volume (GEDV) derived by PiCCO vs. 
traditional PAC-derived filling indicators, including central ve-
nous pressure, pulmonary artery occlusion pressure, and right 
ventricular end-diastolic volume (RVEDV), and did not show 
any significant correlation. The study concluded that the aver-
age bias in continuous cardiac output measurement by both a 
modified PAC and pulse-contour analysis was small in patients 
with septic shock, but variability was large [8].
Another retrospective study published by Siddiqui in 2005 
reviewed charts of 10 ICU patients with sepsis who had PAC 
inserted for fluid management and hemodynamic instability at 
the University Hospital in Karachi, Pakistan in 2004. The au-
thors could not identify any complications related to PAC use, 
but eight of these 10 patients died, and the cause of death in 
these patients was “severe sepsis” [9].
The Fluid and Catheter Treatment Trial (FACTT) designed 
by the ARDSNet Group evaluated treatment of patients with 
acute lung injury or ARDS, in a two by two factorial design, 
whereby patients were randomized to receive PAC vs. central 
venous catheter, and were also randomized to conservative vs. 
liberal fluid strategy. Mortality during the first 60 days was the 
primary outcome of this study, and results were published in 
two manuscripts in the “New England Journal of Medicine” 
in 2006. A part of the study evaluated PAC vs. central venous 
catheter and concluded that PAC-guided therapy was associ-
ated with higher incidence of complications and no improve-
ment in survival [10]. Similarly, the part of the study that eval-
uated conservative vs. liberal fluid administration did not show 
significant difference with regard to mortality, but showed that 
conservative fluid management improved lung function and 
resulted in shorter mechanical ventilation and ICU stay [11].
A meta-analysis published in JAMA in 2005 searched 
MEDLINE (1985 - 2005), the Cochrane Controlled Trials 
Registry (1988 - 2005), the National Institutes of Health Clini-
calTrials.gov database and the US Food and Drug Adminis-
tration (FDA) website for articles evaluating the use of PAC. 
Studies included general surgery patients, ICU patients and pa-
tients admitted with advanced heart failure or diagnosed with 
acute respiratory distress syndrome (ARDS) and/or sepsis. Re-
ported outcome measures included hospital stay, ICU stay and 
mortality. This meta-analysis concluded that, overall, PAC use 
did not increase mortality or hospital length of stay, but did not 
confer any benefit [12].
Another review published by Summerhill and Baram in 
2005 included several RCTs evaluating the role of PAC inser-
tion in critically ill conditions including sepsis, and concluded 
that PAC use did not confer any clear benefit and could even 
be detrimental [24].
Results from an RCT conducted in 36 ICUs in France 
over a 2-year period (1999 - 2001) were published in 2003 and 
showed that management involving use of a PAC did not affect 
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morbidity or mortality in patients with ARDS, shock, or both 
[13]. In addition, a case-control study (nested within a pro-
spective cohort study) published by Yu et al in 2003, evaluated 
the use of the PAC in 141 pairs of patients with severe sepsis in 
eight major academic medical centers in the USA. This study 
showed that mortality and total hospital charges were slightly, 
but not significantly lower in patients with PAC. Patients with 
PAC had significantly increased risk of renal failure within 28 
days after onset of sepsis (OR: 3.48, 95% CI: 1.81 - 6.71), but 
PAC use was not associated with any other organ dysfunction 
[14]. Similarly, results from an RCT on 201 patients (of which 
101 patients had sepsis) published by Rhodes et al in 2002 
showed that patients randomized to have a PAC received sig-
nificantly more fluids in first 24 h and had significantly higher 
renal failure and thrombocytopenia, but there was no differ-
ence in mortality [20].
With regard to PAC-related risk of infection, a prospec-
tive, RCT conducted by Chen et al in Taipei, Taiwan, evaluated 
258 critically ill patients who had PAC insertion and showed 
that the risk of catheter colonization, and the risk of bacteremia 
were not significantly different between patients who had PAC 
for 4 vs. 7 days [15]. Also, a review article on PAC coloniza-
tion and infection published by Rello et al in 1997 showed that, 
compared to other types of catheters, sensitivity in diagnosing 
pulmonary artery colonization can be improved by evaluating 
both the tip and the intradermal segments of the catheter. In 
cases of an indwelling introducer presence, the intradermal 
segment should be replaced by the introducer tip [25].
As PAC efficacy and safety have been under scrutiny 
because of association with increased morbidity and mortal-
ity in observational studies, several researchers attempted to 
evaluate PAC usefulness and necessity. In 1997, the National 
Heart, Lung, and Blood Institute (NHLBI) and the US FDA 
conducted the Pulmonary Artery Catheterization and Clinical 
Outcomes workshop in Alexandria, Virginia to develop recom-
mendations for improved PAC utility and safety. The workshop 
concluded that medical staff needs education obtaining and in-
terpreting PAC data and this education effort should be led by 
professional societies. Areas given high priority for clinical tri-
als included refractory congestive heart failure, ARDS, severe 
sepsis and septic shock, and low-risk coronary artery bypass 
graft surgery [26].
A manuscript published by Sakka et al in 2000 pre-
sented data (51 cardiac output measurements in 12 patients 
with sepsis or septic shock) from a prospective clinical trial 
conducted in Jena, Germany. The study compared four car-
diac output (CO) measurement techniques: pulmonary artery 
thermodilution (CO(PA)), transpulmonary aortic thermodilu-
tion (CO(AORTA)), Fick principle-derived (CO(FICK)), and 
continuous pulmonary artery cardiac output (CCO) measure-
ments, and showed high correlation between the four tech-
niques: CO(PA) and CO(AORTA) had the highest agreement 
(r = 0.98); agreement between CO(PA) or CO(AORTA) and 
CCO was lower, but still very high (r = 0.92 and r = 0.93), 
and all three techniques had comparable correlation with 
CO(FICK) (r = 0.85, r = 0.83, and r = 0.83, respectively). Be-
cause CO measurements can be obtained with similar accuracy 
non-invasively from CO(AORTA), the authors concluded that 
PAC placement is not justified solely for measurement of CO, 
unless CCO measurement is needed [16].
In 1998, Becker reviewed selected outcome studies con-
ducted since 1987 and concluded that there were insufficient 
data from well-conducted prospective, randomized, studies to 
show a mortality or morbidity benefit from use of the PAC. 
The author suggested that until stronger evidence becomes 
available, use of the PAC should not be considered standard of 
care in critically ill patients [27].
In 1997, Parker and Peruzzi published a review on the use 
of the PAC in patients with sepsis and septic shock, based on 
articles published in English between 1984 and 1996, and con-
cluded that PAC use may be appropriate in patients with septic 
shock who do not respond to early resuscitative measures. The 
authors suggested that further research was needed to deter-
mine the role of the PAC in patients with sepsis/septic shock 
[28].
In 1996, a prospective cohort study by Connors et al eval-
uated the association of right heart catheterization within the 
first 24 h of ICU stay with survival, length of ICU stay and cost 
of care, based on data from 5,735 critically ill patients admit-
ted between 1989 and 1994 in five teaching hospitals in Cleve-
land, Ohio. Data analysis in this study showed association of 
right heart catheterization with increased resource utilization 
and higher mortality [17].
In 1995, Schoenenberger et al compared clinical assess-
ment vs. invasive measurements of hemodynamic parameters 
in 47 critically ill ICU patients and assessed changes in therapy 
following PAC insertion. In this study, invasive hemodynamic 
values obtained with insertion of a PAC resulted in a major 
change in treatment in 21% of patients, thereby suggesting that 
the PAC is a very useful tool for guiding therapy [18].
In 1994, a prospective study by Jardin et al compared in-
vasive (right heart catheterization using PAC) vs. non-invasive 
assessment of hemodynamic parameters by measuring CO 
(thermodilution method), cardiac pressures (right heart cathe-
terization) and left ventricular (LV) volumes (two-dimensional 
echocardiography) in 32 patients with septic shock. Because of 
frequent discrepancies between invasive vs. non-invasive data, 
the study concluded that hemodynamic evaluation based on 
PAC should be questioned due to possible CO overestimation 
by the thermodilution method in sepsis [19].
Discussion
The PAC was introduced in cardiology and critical care in the 
1940s [29-31], but the use of the PAC came to critical practice 
after a landmark publication by Swan et al in 1970 [32]. Al-
though PAC use enhances our understanding of cardiovascular 
pathophysiology and helps clinicians optimize hemodynamic 
management, use of the PAC has been criticized due to risks 
associated with its use and absence of convincing evidence 
that PAC use improves patient outcome [12, 33-36].
The PAC allows measurement of central venous pressure, 
right ventricular pressure and pulmonary artery pressure and 
mixed venous oxygen saturation, and calculation of several 
hemodynamic variables, including CO, right ventricular ejec-
tion fraction and peripheral vascular resistance. Tissue oxy-
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genation can be assessed by monitoring mixed venous oxy-
gen saturation (SvO2) after insertion of a fiberoptic PAC, and 
pulmonary artery occlusion pressure can be determined after 
occlusion of the pulmonary artery using the catheter balloon. 
When placement of a PAC is not feasible, insertion of a central 
venous catheter can provide information about tissue oxygen 
supply and demand by measuring mixed venous oxygen satu-
ration (ScvO2) [37].
Traditional indications for PAC insertion are left ventricu-
lar dysfunction, myocardial ischemia, valvular heart disease 
and assessment of patients receiving vasoactive therapy like 
sepsis patients. However, PAC use has been associated with 
significant complications, including arrhythmias that usually 
resolve spontaneously, pneumothorax, thrombosis and hemor-
rhage, and case reports of pulmonary valve endocarditis have 
also been published [38, 39]. When PAC is placed in situ, infec-
tions are another issue which remains of clinical importance, 
also distal catheter migration and pulmonary artery rupture are 
rare but significant complications [40-42]. Therefore, because 
PAC use has been associated with significant complications 
and increased cost, without a clearly documented outcome 
benefit, there is an argument that the PAC should not be used in 
sepsis patients [43], and this is why newer, less invasive tech-
niques, such as echocardiography, Doppler and pulse contour 
techniques have been developed with some success [44]. PAC 
insertion guided by bedside echocardiography is safe [45], 
but older data suggest that heavy colonization of the insertion 
site, percutaneous insertion in the internal jugular vein rather 
than subclavian vein, duration of catheterization longer than 
3 days, and insertion without full barrier precautions signifi-
cantly increase the risk of catheter-related infection [46, 47]. 
PAC insertion can also cause complications years later: a case 
report published in 2013 described a case where retained PAC 
fragment was incidentally found lodged in the right heart of a 
patient 16 years after PAC insertion, thereby highlighting the 
importance of vigilance during PAC insertion [48].
Regarding the use of PAC in sepsis, the consensus confer-
ence of 1997 concluded that use of the PAC may be beneficial 
in patients with septic shock unresponsive to early resuscitative 
measures. In such cases, maintenance of normal hemodynamic 
targets should be the main goal [49]. In 2004, the American 
College of Critical Care Medicine updated the recommenda-
tions for hemodynamic support in adult patients with sepsis, 
and proposed a level D recommendation for invasive hemo-
dynamic monitoring in patients who do not respond to initial 
resuscitative efforts. In such cases, the guidelines recommend 
administration of fluids titrated to defined hemodynamic goals, 
and adequacy of cardiac filling pressures can be determined by 
the response of the CO to increasing pulmonary artery occlu-
sion pressure. In this consensus, most experts agreed that the 
maximum benefit can usually be achieved when pulmonary 
artery occlusion pressure is in the 12 - 15 mm Hg range [50].
Our literature search shows that there is ongoing debate 
regarding the benefit from the PAC use. Observational studies 
suggest that use of the PAC is not associated with improved 
outcome and may even increase morbidity and mortality. Simi-
larly, randomized controlled trials in sepsis patients and other 
critically ill patients failed to demonstrate a mortality benefit 
from use of the PAC [51]. Pulmonary artery catheterization 
seems to be more accurate than clinical assessment alone in 
evaluating the cause of shock (hypovolemic, cardiogenic or 
septic), and is also useful in evaluating the cause of pulmo-
nary edema (cardiogenic vs. non-cardiogenic). The PAC may 
be useful in cases where hemodynamic intervention with fluids 
and dopamine is ineffective, and also in cases where there is 
need for precise evaluation of cardiac preload and optimiza-
tion of oxygen transport. Mixed venous oxygen content (com-
monly measured as oxygen saturation) is a highly relevant 
parameter in the monitoring of critically ill patients, but its 
measurement requires catheterization of the pulmonary artery. 
As cardiac dysfunction is a very common and severe compli-
cation of septic shock, the catheterization of the pulmonary 
artery is used to monitor the effects of inotropic therapy, to 
alert clinicians for cardiovascular changes and optimize ther-
apy. However, a matter of debate for its use is the fact that 
although treatment corner stones for sepsis include adequate 
volume resuscitation and improvement of tissue oxygenation, 
specific hemodynamic endpoints remain controversial and di-
rect measurements of tissue oxygenation are not possible. This 
would suggest a need for a consensus opinion on how PACs 
are actually used to obtain the different physiological variables 
which can influence patient management.
PAC use provides hemodynamic data that can assist de-
cision-making in critically ill patients, and many clinicians 
use advanced hemodynamic monitoring and obtain invasive 
or non-invasive measures of CO to guide therapy in critical 
illness. The PAC-Man study, which was published in 2005, 
evaluated 1,014 critically ill patients randomly assigned to 
management with (n = 519) vs. without (n = 522) a PAC, and 
showed no evidence or benefit or harm from use of the PAC, 
but also showed that 80% of patients in the non-PAC group 
underwent an alternative form of CO monitoring [52].
Every procedure in medicine has its own indications, and 
the role of the PAC remains contentious. Of course there are 
circumstances where use of the PAC may be considered, such 
as in sepsis patients with significant pre-existing comorbidities 
or presence of severe ARDS, in sepsis patients with persis-
tent deterioration and multiple organ failure, or in cases with 
diagnostic dilemmas, such as probable co-existing underlying 
pathologies. Pulmonary artery catheterization has been in clin-
ical use since 1970, and has been a valuable tool for the assess-
ment of cardiorespiratory performance in critically ill patients, 
but there has been criticism that PAC use has encouraged phy-
sicians and intensivists to make decisions based on numerical 
targets rather than clinical signs, and incorrect interpretation 
of data has also been a concern [53]. The best approach for 
use of the PAC seems to be careful clinical management that 
takes into account data derived from advanced hemodynamic 
monitoring, invasive and/or non-invasive [54]. As there is in-
creasing use of non-invasive methods for the assessment and 
management of cardiovascular complications in sepsis, there 
is need for large prospective trials in order to define whether 
use of the PAC offers benefits in patients with severe sepsis 
and septic shock.
An interesting Editorial published by Pr Vincent in Criti-
cal Care Medicine in 2011 discussed the declining use of the 
PAC in recent years, and classified the reasons for reduced 
PAC use as “bad” and “good”. “Bad” reasons include the pub-
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lication of randomized controlled trials failing to prove a clear 
benefit, the availability of less invasive monitoring techniques, 
the use of ScvO2 monitoring and the fashion that follows the 
trend, whereas “good” reasons include the widespread use of 
echocardiography, efforts to reduce healthcare expenses, and 
the tendency to avoid overuse of the PAC in patients who will 
not clearly benefit [55].
Finally, although an Editorial published by Dr. Marik in 
the Annals of Intensive Care in 2013 reported the “Obituary 
of the Pulmonary Artery Catheter” [56], we believe that the 
PAC is still a very useful tool for a limited number of criti-
cally ill patients, and therefore its optimal use deserves further 
investigation.
Conclusions
Pulmonary artery catheterization has a significant role in the 
management of patients with sepsis and septic shock, not only 
as a diagnostic tool, but also as a means to monitor the hemo-
dynamic response to therapy. Although clinical management 
of hemodynamic instability in sepsis is facilitated by pulmo-
nary artery catheterization, our literature review shows that 
PAC use has not been associated with clear benefit with regard 
to outcome in sepsis, and use of the PAC in the ICU is declin-
ing all over the world. The PAC remains a valuable educational 
tool for the assessment of sepsis patients, but because its effi-
cacy and safety is under scrutiny, well-designed large prospec-
tive clinical studies are needed to better assess its role.
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